These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29153114)

  • 1. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.
    Park C; Wang G; Durthaler JM; Fang J
    Am J Prev Med; 2017 Dec; 53(6S2):S131-S142. PubMed ID: 29153114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
    Siegel D; Lopez J; Meier J; Cunningham F
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
    Richter A; Gondek K; Ostrowski C; Dombeck M; Lamb S
    Manag Care Interface; 2001 Jul; 14(7):61-9. PubMed ID: 11481819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
    Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
    Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
    J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of chemical therapies for treating diabetic hypertension.
    Sarafidis PA; Alexandrou ME; Ruilope LM
    Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
    Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wealth-related Inequality in Utilization of Antihypertensive Medicines in Iran: an Ecological Study on Population Level Data.
    Hashemi-Meshkini A; Kebriaeezadeh A; Jamshidi H; Akbari-Sari A; Rezaei-Darzi E; Mehdipour P; Nikfar S; Farzadfar F
    Arch Iran Med; 2016 Feb; 19(2):116-22. PubMed ID: 26838082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care.
    Schäfer HH; Scheunert U
    Swiss Med Wkly; 2013; 143():w13854. PubMed ID: 24163048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health outcomes and economic consequences of using angiotensin-converting enzyme inhibitors in comparison with angiotensin receptor blockers in the treatment of arterial hypertension in the contemporary Polish setting.
    Wrona W; Budka K; Filipiak KJ; Niewada M; Wojtyniak B; Zdrojewski T
    Kardiol Pol; 2016; 74(9):1016-24. PubMed ID: 27112942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
    Brown A; Captain B
    Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
    Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
    Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel blockers versus other classes of drugs for hypertension.
    Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
    Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causal relationship between antihypertensive drugs and depression: a Mendelian randomization study of drug targets.
    Yang Z; Li J; Huang P; Li Z; He J; Cai D; Lai Y
    Front Endocrinol (Lausanne); 2024; 15():1411343. PubMed ID: 39184138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.